Document Detail


Slow-release metoprolol and nifedipine in essential hypertension: 24 hour noninvasive ambulatory blood pressure monitoring.
MedLine Citation:
PMID:  2455155     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess the efficacy and tolerability of metoprolol (MET), 200 mg slow release (SR) q.d., and nifedipine (NIF), 20 mg SR b.i.d., 20 mildly to moderately hypertensive outpatients (14 men and 6 women; mean age 41.5 years, range 27-49 years) were studied. After being withdrawn from previous antihypertensive treatments, the patients were given single-blind placebo for 2 weeks and thereafter, in double-blind, randomized sequence, MET and NIF, both for 2 weeks. At the end of each period of the study, blood pressure (BP) was recorded for 24 h using a noninvasive ambulatory BP monitoring device (ICR System) with readings taken every 10 min (from 6 a.m. to 6 p.m.), 15 min (from 6 to 12 p.m.), and 20 min (from 12 p.m. to 6 a.m.). Five patients did not complete the study because of the occurrence of unwanted effects (one patient on MET and four patients on NIF). In the 15 patients who concluded the study both drugs significantly reduced (p less than 0.01), in comparison with placebo, systolic BP (SBP), mean arterial pressure (MAP), and diastolic BP (DBP) throughout the 24 h (MET: -16.9, -11.5, and -8.9 mm Hg; NIF: -12.7, -8.4, and -6.6 mm Hg, respectively). In comparison with NIF, SBP and MAP but not DBP were significantly reduced by MET (p less than 0.01 and p less than 0.05, respectively). We conclude that in our patient population MET was more effective and better tolerated than NIF. A possible explanation could be the relatively young age of the subjects we studied.
Authors:
S Lattuada; M Antivalle; M Rindi; M Montanari; D Alberti; A Libretti
Related Documents :
18772645 - Blood pressure control in patients with comorbidities.
18685605 - The effects of sour tea (hibiscus sabdariffa) on hypertension in patients with type ii ...
17261465 - Reduction in arterial stiffness with angiotensin ii antagonism and converting enzyme in...
39845 - The effect of medroxyprogesterone acetate on blood pressure.
24097425 - Role of 20-hete,trp channels & bkca in dysregulation of pressure-induced ca2+ signaling...
8539005 - Biphasic intraocular pressure response to laser irradiation of the iris in rabbits.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  10 Suppl 10     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1987  
Date Detail:
Created Date:  1988-08-04     Completed Date:  1988-08-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S99-101     Citation Subset:  IM    
Affiliation:
Clinica Medica, University of Milan-Ospedale L. Sacco, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Ambulatory Care
Blood Pressure
Delayed-Action Preparations
Double-Blind Method
Female
Humans
Hypertension / drug therapy*,  physiopathology
Male
Metoprolol / adverse effects,  therapeutic use*
Middle Aged
Monitoring, Physiologic
Nifedipine / adverse effects,  therapeutic use*
Random Allocation
Chemical
Reg. No./Substance:
0/Delayed-Action Preparations; 21829-25-4/Nifedipine; 37350-58-6/Metoprolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, ...
Next Document:  Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascul...